Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

Warning: Surfing the internet in class is now linked to poorer test scores, even among the most intelligent and motivated of students. Warning: Surfing the internet in class is now linked to poorer ...